celecoxib has been researched along with melatonin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abdel-Salam, OM; Arbid, MS; Baiuomy, AR | 1 |
| Ahlers, I; Ahlersova, E; Bojkova, B; Kajo, K; Kassayova, M; Kubatka, P; Orendas, P; Pec, M | 1 |
| Cruz, A; Montilla, P; Muntané, J; Padillo, FJ; Perea, MD; Ruiz-Rabelo, JF; Tasset, I; Túnez, I | 1 |
| Abidin, ZU; Ahmad, S; Al Kury, LT; Alvi, AM; Faheem, M; Irshad, N; Khalil, AAK; Khan, AU; Li, S; Malik, I; Shah, FA; Zeb, A | 1 |
| Alam, M; Aman, A; Badshah, H; Khan, AU; Malik, Z; Sarwar, S; Shah, FA; Uddin, Z; Ullah, U | 1 |
7 other study(ies) available for celecoxib and melatonin
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Studies on the anti-inflammatory effect of fluoxetine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Carrageenan; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Fluoxetine; Foot; Imipramine; Indomethacin; Inflammation; Lactones; Melatonin; Pyrazoles; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Sulfones; Time Factors; Trazodone | 2004 |
Celecoxib and melatonin in prevention of female rat mammary carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Celecoxib; Drug Therapy, Combination; Eating; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2009 |
Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer.
Topics: Animals; Antioxidants; Catalase; Celecoxib; Cricetinae; Cyclooxygenase 2 Inhibitors; Glutathione; Glutathione Peroxidase; Lipid Peroxides; Melatonin; Mesocricetus; Oxidative Stress; Pancreatic Neoplasms; Pyrazoles; Sulfonamides; Superoxide Dismutase | 2010 |
Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach.
Topics: Animals; Celecoxib; Computational Biology; Disease Models, Animal; Ethanol; Injections, Intraperitoneal; Male; Melatonin; Molecular Docking Simulation; Neurodegenerative Diseases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2019 |
Hepatoprotective effects of melatonin and celecoxib against ethanol-induced hepatotoxicity in rats.
Topics: Animals; Biomarkers; Celecoxib; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethanol; Lipid Peroxidation; Liver Function Tests; Male; Melatonin; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley | 2020 |